
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5687721
[patent_doc_number] => 20060286036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Methods and compositions for inhibiting HIV infection'
[patent_app_type] => utility
[patent_app_number] => 11/408551
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11962
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286036.pdf
[firstpage_image] =>[orig_patent_app_number] => 11408551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/408551 | Methods and compositions for inhibiting HIV infection | Apr 20, 2006 | Issued |
Array
(
[id] => 5732309
[patent_doc_number] => 20060257426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Nanoemulsion vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/403316
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 74382
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403316 | Nanoemulsion vaccines | Apr 12, 2006 | Abandoned |
Array
(
[id] => 5922512
[patent_doc_number] => 20060240516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain'
[patent_app_type] => utility
[patent_app_number] => 11/396196
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18815
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240516.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396196 | Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain | Mar 29, 2006 | Issued |
Array
(
[id] => 5514285
[patent_doc_number] => 20090214591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/908942
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11178
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908942 | Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases | Mar 16, 2006 | Abandoned |
Array
(
[id] => 13335
[patent_doc_number] => 07807437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/375580
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18018
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375580 | Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof | Mar 14, 2006 | Issued |
Array
(
[id] => 5888964
[patent_doc_number] => 20060275897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'HIV vaccines based on Env of multiple clades of HIV'
[patent_app_type] => utility
[patent_app_number] => 11/376484
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 110
[patent_figures_cnt] => 110
[patent_no_of_words] => 37733
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275897.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376484
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376484 | HIV vaccines based on Env of multiple clades of HIV | Mar 14, 2006 | Abandoned |
Array
(
[id] => 196442
[patent_doc_number] => 07638319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1'
[patent_app_type] => utility
[patent_app_number] => 11/369010
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 9322
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369010 | Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1 | Mar 6, 2006 | Issued |
Array
(
[id] => 6252195
[patent_doc_number] => 20100028383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Chemically defined stabiliser'
[patent_app_type] => utility
[patent_app_number] => 11/908028
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10212
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908028
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908028 | Chemically defined vaccine stabiliser | Mar 6, 2006 | Issued |
Array
(
[id] => 4820175
[patent_doc_number] => 20080226548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Methods of Applying Ionization Radiation for Therapy of Hiv Infection'
[patent_app_type] => utility
[patent_app_number] => 11/885769
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11045
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226548.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885769 | Methods of Applying Ionization Radiation for Therapy of Hiv Infection | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5785382
[patent_doc_number] => 20060205040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Compositions for use in identification of adventitious viruses'
[patent_app_type] => utility
[patent_app_number] => 11/368233
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28763
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368233
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368233 | Compositions for use in identification of adventitious viruses | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5514286
[patent_doc_number] => 20090214592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Adjuvant composition comprising aluminium phosphate and 3D-MPL'
[patent_app_type] => utility
[patent_app_number] => 11/884610
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7473
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884610
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884610 | Adjuvant composition comprising aluminium phosphate and 3D-MPL | Feb 15, 2006 | Abandoned |
Array
(
[id] => 6126480
[patent_doc_number] => 20110086338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates'
[patent_app_type] => utility
[patent_app_number] => 11/884604
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14610
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884604
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884604 | Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates | Feb 15, 2006 | Abandoned |
Array
(
[id] => 270203
[patent_doc_number] => 07563437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Methods and compositions for impairing multiplication of HIV-1'
[patent_app_type] => utility
[patent_app_number] => 11/353293
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11737
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353293 | Methods and compositions for impairing multiplication of HIV-1 | Feb 12, 2006 | Issued |
Array
(
[id] => 4839819
[patent_doc_number] => 20080280305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection'
[patent_app_type] => utility
[patent_app_number] => 11/795671
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795671
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795671 | Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection | Feb 12, 2006 | Abandoned |
Array
(
[id] => 393785
[patent_doc_number] => 07297477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-20
[patent_title] => 'Methods and compositions for detecting viral nucleic acid in a cell'
[patent_app_type] => utility
[patent_app_number] => 11/353719
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7424
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/297/07297477.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353719 | Methods and compositions for detecting viral nucleic acid in a cell | Feb 12, 2006 | Issued |
Array
(
[id] => 5154297
[patent_doc_number] => 20070037180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV\'s'
[patent_app_type] => utility
[patent_app_number] => 11/350453
[patent_app_country] => US
[patent_app_date] => 2006-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3184
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037180.pdf
[firstpage_image] =>[orig_patent_app_number] => 11350453
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/350453 | Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV's | Feb 8, 2006 | Abandoned |
Array
(
[id] => 6479442
[patent_doc_number] => 20100041732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'METHODS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/815311
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8480
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041732.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815311 | METHODS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV INFECTION | Feb 5, 2006 | Abandoned |
Array
(
[id] => 4475808
[patent_doc_number] => 07906122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination'
[patent_app_type] => utility
[patent_app_number] => 11/345624
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 15884
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906122.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345624 | Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination | Feb 1, 2006 | Issued |
Array
(
[id] => 5912927
[patent_doc_number] => 20060127989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Antigenic fragment of human T-lymphotropic virus'
[patent_app_type] => utility
[patent_app_number] => 11/345110
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4368
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345110
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345110 | Antigenic fragment of human T-lymphotropic virus | Jan 30, 2006 | Abandoned |
Array
(
[id] => 5558735
[patent_doc_number] => 20090270312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION'
[patent_app_type] => utility
[patent_app_number] => 11/722064
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14749
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722064 | HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION | Jan 23, 2006 | Abandoned |